Editorial

Containing contraceptive costs

Norman David Goldstuck

Abstract


The cost of the newer hormone-based long-acting reversible contraceptive (LARC) methods, which are most effective in preventing unwanted pregnancy because their use does not demand daily compliance, is still high. The author suggests that the lifespan of these products is longer than their licence dictates. Clinicians should use their clinical judgement, replacing the device for users who seem concerned, and supporting users who request extended use. He concludes that cheaper and longer-acting hormonal LARC methods are on the way.


Author's affiliations

Norman David Goldstuck, Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, Western Cape 7505,

Full Text

PDF (71KB)

Keywords

Contraception; Long-acting

Cite this article

South African Medical Journal 2015;105(4):286. DOI:10.7196/SAMJ.9480

Article History

Date submitted: 2015-02-11
Date published: 2015-03-18

Article Views

Abstract views: 1181
Full text views: 400

Comments on this article

*Read our policy for posting comments here